Curcumin-based Synergistic Systems for Neurokinin-3 Receptor Modulation

A comprehensive system integrating curcumin compositions with distinct technologies to create a powerful platform for treating neurokinin-3 receptor-related disorders and optimizing curcumin composition efficacy.

The original patent identified curcumin as a potent NK3 antagonist, but its limitations included the lack of a comprehensive system for treating NK3-related disorders. The new inventive concept addresses this limitation by integrating curcumin compositions with AI, IoT, blockchain, and new materials to create a synergistic system.

The inventive concept comprises four distinct systems: a wearable device with an AI-powered analytics module for tracking neurological activity and identifying personalized treatment regimens; an IoT-enabled sensor system for monitoring physiological responses and adjusting curcumin composition formulations; a blockchain-based platform for tracking and verifying curcumin composition authenticity; and a composite material integrating curcumin with biocompatible polymers for biomedical applications. These systems work in tandem to provide a comprehensive platform for treating NK3-related disorders.

The new claims introduce novel combinations of curcumin compositions with distinct technologies, providing a synergistic system that is not obvious from the original patent. The integration of AI, IoT, blockchain, and new materials with curcumin compositions creates a new, more powerful system for treating NK3-related disorders.

Alternative embodiments could include integrating curcumin compositions with other distinct technologies, such as virtual reality or nanotechnology. Variations could include using different ratios of curcumin to other components or incorporating additional ingredients to enhance the system's efficacy.

The inventive concept has significant commercial potential in the pharmaceutical and biomedical industries, particularly in the areas of neurological disorders and personalized medicine. The system's ability to provide comprehensive treatment and monitoring options could lead to improved patient outcomes and increased market share.